List of Excipients in API HYDROCORTISONE BUTYRATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing HYDROCORTISONE BUTYRATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch Health US LLC | LOCOID | hydrocortisone butyrate | 16781-382 | ANHYDROUS CITRIC ACID | |
| Bausch Health US LLC | LOCOID | hydrocortisone butyrate | 16781-382 | BUTYLPARABEN | |
| Bausch Health US LLC | LOCOID | hydrocortisone butyrate | 16781-382 | CETETH-20 | |
| Bausch Health US LLC | LOCOID | hydrocortisone butyrate | 16781-382 | CETOSTEARYL ALCOHOL | |
| Bausch Health US LLC | LOCOID | hydrocortisone butyrate | 16781-382 | MINERAL OIL | |
| Bausch Health US LLC | LOCOID | hydrocortisone butyrate | 16781-382 | PETROLATUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing HYDROCORTISONE BUTYRATE
Detailed excipient profiles for HYDROCORTISONE BUTYRATE
Excipient focus: ANHYDROUS CITRIC ACID
HYDROCORTISONE BUTYRATE drug variants containing ANHYDROUS CITRIC ACID
HYDROCORTISONE BUTYRATE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS TRISODIUM CITRATE
HYDROCORTISONE BUTYRATE drug variants containing ANHYDROUS TRISODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | hydrocortisone butyrate | 68462-464 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing ANHYDROUS TRISODIUM CITRATE
Excipient focus: BUTYLATED HYDROXYTOLUENE
HYDROCORTISONE BUTYRATE drug variants containing BUTYLATED HYDROXYTOLUENE
HYDROCORTISONE BUTYRATE drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: BUTYLPARABEN
HYDROCORTISONE BUTYRATE drug variants containing BUTYLPARABEN
HYDROCORTISONE BUTYRATE drug variants not containing BUTYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | hydrocortisone butyrate | 16781-391 |
| Taro Pharmaceuticals USA Inc | hydrocortisone butyrate | 51672-4061 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-271 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-273 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETETH-20
HYDROCORTISONE BUTYRATE drug variants containing CETETH-20
HYDROCORTISONE BUTYRATE drug variants not containing CETETH-20
Excipient focus: CETOSTEARYL ALCOHOL
HYDROCORTISONE BUTYRATE drug variants containing CETOSTEARYL ALCOHOL
HYDROCORTISONE BUTYRATE drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | hydrocortisone butyrate | 16781-391 |
| Taro Pharmaceuticals USA Inc | hydrocortisone butyrate | 51672-4061 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-271 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-273 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
HYDROCORTISONE BUTYRATE drug variants containing CITRIC ACID MONOHYDRATE
HYDROCORTISONE BUTYRATE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: GLYCERIN
HYDROCORTISONE BUTYRATE drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | hydrocortisone butyrate | 16781-391 |
| Taro Pharmaceuticals USA Inc | hydrocortisone butyrate | 51672-4061 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-273 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing GLYCERIN
Excipient focus: GLYCERYL MONOSTEARATE
HYDROCORTISONE BUTYRATE drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | hydrocortisone butyrate | 68462-464 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: ISOPROPYL ALCOHOL
HYDROCORTISONE BUTYRATE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | hydrocortisone butyrate | 16781-391 |
| Taro Pharmaceuticals USA Inc | hydrocortisone butyrate | 51672-4061 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-273 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LIGHT MINERAL OIL
HYDROCORTISONE BUTYRATE drug variants containing LIGHT MINERAL OIL
HYDROCORTISONE BUTYRATE drug variants not containing LIGHT MINERAL OIL
Excipient focus: MINERAL OIL
HYDROCORTISONE BUTYRATE drug variants containing MINERAL OIL
HYDROCORTISONE BUTYRATE drug variants not containing MINERAL OIL
Excipient focus: PETROLATUM
HYDROCORTISONE BUTYRATE drug variants containing PETROLATUM
HYDROCORTISONE BUTYRATE drug variants not containing PETROLATUM
Excipient focus: POLYETHYLENE GLYCOL
HYDROCORTISONE BUTYRATE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | hydrocortisone butyrate | 68462-464 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-271 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POVIDONE
HYDROCORTISONE BUTYRATE drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | hydrocortisone butyrate | 16781-391 |
| Taro Pharmaceuticals USA Inc | hydrocortisone butyrate | 51672-4061 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-273 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing POVIDONE
Excipient focus: PROPYLPARABEN
HYDROCORTISONE BUTYRATE drug variants containing PROPYLPARABEN
HYDROCORTISONE BUTYRATE drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | hydrocortisone butyrate | 16781-391 |
| Taro Pharmaceuticals USA Inc | hydrocortisone butyrate | 51672-4061 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-271 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-273 |
| >Company | >Ingredient | >NDC |
Excipient focus: SAFFLOWER OIL
HYDROCORTISONE BUTYRATE drug variants containing SAFFLOWER OIL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | hydrocortisone butyrate | 16781-392 |
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-392 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing SAFFLOWER OIL
Excipient focus: SODIUM CITRATE
HYDROCORTISONE BUTYRATE drug variants containing SODIUM CITRATE
HYDROCORTISONE BUTYRATE drug variants not containing SODIUM CITRATE
Excipient focus: SORBITAN MONOSTEARATE
HYDROCORTISONE BUTYRATE drug variants containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Glenmark Pharmaceuticals Inc USA | hydrocortisone butyrate | 68462-464 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing SORBITAN MONOSTEARATE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
HYDROCORTISONE BUTYRATE drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | hydrocortisone butyrate | 51672-4061 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
HYDROCORTISONE BUTYRATE drug variants containing WATER
HYDROCORTISONE BUTYRATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Oceanside Pharmaceuticals | hydrocortisone butyrate | 68682-271 |
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE PETROLATUM
HYDROCORTISONE BUTYRATE drug variants containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| The J Molner Company LLC | hydrocortisone butyrate | 83148-012 |
| >Company | >Ingredient | >NDC |
HYDROCORTISONE BUTYRATE drug variants not containing WHITE PETROLATUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
